March Altus Capital Management as of Sept. 30, 2016
Portfolio Holdings for March Altus Capital Management
March Altus Capital Management holds 11 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Edwards Lifesciences (EW) | 26.1 | $4.2M | 35k | 120.57 | |
| ACADIA Pharmaceuticals (ACAD) | 14.5 | $2.3M | 73k | 31.81 | |
| Aratana Therapeutics | 12.8 | $2.0M | 219k | 9.36 | |
| Johnson & Johnson (JNJ) | 9.6 | $1.5M | 13k | 118.15 | |
| Dex (DXCM) | 7.8 | $1.2M | 14k | 87.68 | |
| Eli Lilly & Co. (LLY) | 6.7 | $1.1M | 13k | 80.24 | |
| Tesaro | 6.3 | $1.0M | 10k | 100.20 | |
| Zoetis Inc Cl A (ZTS) | 5.2 | $827k | 16k | 52.01 | |
| Biogen Idec (BIIB) | 5.1 | $814k | 2.6k | 313.08 | |
| Alexion Pharmaceuticals | 4.8 | $760k | 6.2k | 122.60 | |
| Regeneron Pharmaceuticals (REGN) | 1.3 | $201k | 500.00 | 402.00 |
